Remapping of the RP15 Locus for X-Linked Cone-Rod Degeneration to Xp11.4-p21.1, and Identification of a De Novo Insertion in the RPGR Exon ORF15  by Mears, Alan J. et al.
Am. J. Hum. Genet. 67:1000–1003, 2000
1000
Report
Remapping of the RP15 Locus for X-Linked Cone-Rod Degeneration to
Xp11.4-p21.1, and Identification of a De Novo Insertion in the RPGR
Exon ORF15
Alan J. Mears,1 Suja Hiriyanna,1 Raf Vervoort,3 Beverly Yashar,1 Linn Gieser,1 Stacey Fahrner,1
Stephen P. Daiger,4 John R. Heckenlively,5 Paul A. Sieving,1 Alan F. Wright,3 and
Anand Swaroop1,2
Departments of 1Ophthalmology and Visual Sciences and 2Human Genetics, University of Michigan, Ann Arbor; 3MRC Human Genetics
Unit, Western General Hospital, Edinburgh; 4Department of Ophthalmology and Visual Science, University of Texas–Houston Health Science
Center, Houston; and 5Jules Stein Eye Institute, University of California, Los Angeles
X-linked forms of retinitis pigmentosa (XLRP) are among the most severe, because of their early onset, often
leading to significant vision loss before the 4th decade. Previously, the RP15 locus was assigned to Xp22, by
linkage analysis of a single pedigree with “X-linked dominant cone-rod degeneration.” After clinical reeval-
uation of a female in this pedigree identified her as affected, we remapped the disease to a 19.5-cM interval
(DXS1219–DXS993) at Xp11.4-p21.1. This new interval overlapped both RP3 (RPGR) and COD1. Sequencing
of the previously published exons of RPGR revealed no mutations, but a de novo insertion was detected in
the new RPGR exon, ORF15. The identification of an RPGR mutation in a family with a severe form of cone
and rod degeneration suggests that RPGR mutations may encompass a broader phenotypic spectrum than has
previously been recognized in “typical” retinitis pigmentosa.
The X-linked forms of retinitis pigmentosa (XLRP
[MIM 268000]) are among the most severe because
of their early onset, often leading to significant vision
loss before the fourth decade. Six XLRP loci have been
localized by linkage: RP2 (MIM 312600), RP3 (MIM
312610), RP6 (MIM 312612), RP15 (MIM 300029),
RP23, and RP24 (MIM 300155). The two major loci,
RP2 and RP3, are clinically indistinguishable and map
∼20 cM apart on Xp21. RP3 accounts for 70% of
XLRP (Ott et al. 1990). The RPGR (retinitis pigmen-
tosa GTPase regulator) gene isolated from the RP3
region is mutated in 20% of families with XLRP, in-
cluding those in which there is evidence of mapping
to the RP3 genetic interval (Buraczynska et al. 1997;
Fujita et al. 1997). This discrepancy between pre-
dicted and identified mutations in XLRP has recently
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been resolved by the discovery of a mutational hotspot
in a new RPGR exon, ORF15 (Vervoort et al. 2000).
The RP15 locus had been mapped to Xp22.13-
p22.11 by linkage analysis of a pedigree described as
having dominant cone-rod degeneration (McGuire et
al. 1995) although there has been some controversy
regarding nomenclature (Daiger et al. 1996; Ingle-
hearn and Hardcastle 1996). Both affected males and
“carrier” females presented an early cone involvement
in disease. This is different from the typical rod-pre-
dominant manifestation of XLRP (Bird 1975; Fish-
man et al. 1988). RP15 was localized to an 8.4-cM
interval, flanked distally by DXS1229 and proximally
by DXS1048. To further delineate the RP15 interval,
for positional cloning, additional markers were ana-
lyzed, and new family members were recruited. Re-
cently, it has been discovered that individual IV:4 (fig.
1), originally described as an unaffected female
(McGuire et al. 1995), now has a son (V:2) affected
with retinitis pigmentosa (RP). In addition, a more
recent ophthalmic examination of IV:4 (at age 31
years) has revealed fundus changes (diffuse atrophy,
minimal pigment deposits, and attenuation of retinal
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Figure 1 Haplotype analysis of pedigree. Affected individuals are denoted by blackened symbols. Individual I:1 is 92 years old and clinically
normal. The clinical status of individuals IV:11 and IV:14 (12 and 2 years old, respectively) is unknown. Individual IV:4 originally had been described
as clinically normal (McGuire et al. 1995), but, on more recent ophthalmic examination, has been determined as being affected. The blackened
bars represent the disease haplotype segregating in this family; the hatched bar represents the haplotype of III:7, inferred on the basis of the daughter,
IV:9.
vessels) and abnormal results on electroretinography
(photopic 50% of normal, scotopic 60% of normal)
that are consistent with the disease expressed by car-
rier females in this family. IV:4 has the normal hap-
lotype for the entire RP15 interval, indicating that
the map position for the disease locus in this family
had been incorrectly assigned. Haplotype analysis
with the X-chromosome microsatellite markers re-
mapped the disease locus distal to DXS8054 and
proximal to DXS1048 (fig. 1). Further haplotype anal-
ysis of two affected female recombinants—IV:4 and
IV:9—further delineated the critical region, as being
a 19.5-cM interval flanked proximally by DXS993
and distally by DXS1219 (fig. 2). This newly defined
interval overlaps with both RP3 (RPGR) and COD1
(MIM 304020 [Seymour et al. 1998]). Direct sequenc-
ing of the published RPGR exons (Meindl et al. 1996;
Roepman et al. 1996) in individuals IV:1 (affected
male) and IV:2 (normal male) did not reveal any caus-
ative mutation. However, analysis of the novel RPGR
exon ORF15 (Vervoort et al. 2000) identified a single-
nucleotide insertion in affected male IV:1 (fig. 3). This
mutation results in a frameshift and is predicted to
result in premature truncation of the RPGR protein.
Interestingly, individual I:1, who has no RP-related
visual problems, had 10 unaffected children and 1
affected child (II:1). The mutation was not detected
in I:1 but was detected in II:1 and, in subsequent gen-
erations, cosegregates with the disease in this pedi-
gree, indicating that it had been a de novo mutation.
ORF15, because of the composition and nature of its
sequence, is predicted to have a high mutation rate
(Vervoort et al. 2000). The identification of a muta-
tion in the RPGR gene in this family described as
having a severe form of cone and rod degeneration,
the cone-degeneration phenotype observed in the
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Figure 2 Map of critical recombinants defining the disease interval. The microsatellite markers used to define the interval, as well as their
genetic distances, are shown at the top. Relevant disease loci in the region are shown in boxes, relative to the markers. The thickened black lines
indicate the disease haplotype in individuals IV:4 and IV:9 (affected females). The disease interval maps between DXS1219 andDXS993, overlapping
both RPGR (RP3) and COD1.
Figure 3 Identification of theRPGRmutation. a, results of DNA-
sequence autoradiograms of IV:2 and IV:1, showing partial sequence
from a reverse primer in ORF15. The one-base insertion is indicated by
the arrow; this insertion was not detected in 72 unaffected individuals
(controls). b,Coding sequence and translation comparison of the normal
allele and the mutant allele. Partial sequence of ORF15, as well as the
predicted translation product, is shown. The single-nucleotide insertion
is underlined. The frameshift results in nine novel amino acids and, then,
in truncation of the protein product, 501 amino acids premature of the
ORF15 stop codon.
Rpgr-knockout mouse (Hong et al. 2000), and the
broad clinical spectrum observed in families with
XLRP (Keith et al. 1991; Souied et al. 1997; Vervoort
et al. 2000) suggest that RPGR mutations may en-
compass a broader phenotypic spectrum than previ-
ously has been recognized in “typical” RP.
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